US 12018257
Single-stranded RNA-editing oligonucleotides
granted A61KA61K31/7125A61P
Quick answer
US patent 12018257 (Single-stranded RNA-editing oligonucleotides) held by ProQR Therapeutics II B.V. expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ProQR Therapeutics II B.V.
- Grant date
- Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/7125, A61P, A61P1/04, A61P11/00